Synthesis, in vitro and in silico anticancer evaluations of novel styryl 1,3,4-oxadiazole-sulfonamide hybrids for colorectal cancer
Bioorganic & Medicinal Chemistry · 2025-12 · 131 · 118409
DOI: 10.1016/j.bmc.2025.118409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025-12. Verfasst von Hawkar I Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Education, University of Sulaimani, Old Campus, 46001, Kurdistan Region, Iraq; College of Science, Department of …. Hauptthemen laut MEDLINE: Oxadiazoles, Sulfonamides, Antineoplastic Agents, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Salahaddin University-Erbil, Bolu Abant İzzet Baysal University.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a major contributor to cancer mortality, necessitating novel therapeutic strategies to overcome drug resistance and the adverse effects of current chemotherapeutics. This study aimed to synthesize a new series of styryl-1,3,4-oxadiazole-sulfonamide hybrids and to evaluate their cytotoxicities in vitro, stability of protein-ligand complex, druggability, and solubility properties in silico to find out their potential as an effective anticancer agent for CRC treatment. An efficient multistep approach was used involving a facile reduction of 4-nitrophenyl substituted styryl-1,3,4-oxadiazoles to yield corresponding anilines (10a-e), which were subsequently converted into benzenesulfonamides (11a-o). All title compounds were obtained in high yields and characterized using FTIR, NMR, and HRMS analysis. The newly synthesized anilines (10) and sulfonamides (11) were then evaluated for their antiproliferative activities against CRC cell lines, HCT116 and SW48. The results of in vitro studies revealed significant cytotoxic potential of some compounds such as 10a, 10c, 11f, 11h, 11i, and 11l showing potent activity (IC50 < 25 μM). In particular, compound 11c exhibited the strongest activity (IC50: 18.47 μM), which is slightly better than reference drug daunorubicin (IC50: 22.91 μM) against HCT116 cell lines. Furthermore, molecular docking and dynamic simulations studies confirmed the strong interactions between the compounds (10,11) and TNIK kinase protein, underpinning their significant anticancer effects. The findings highlight that styryl-1,3,4-oxadiazole aniline derivatives, particularly 11c, 11f, 11h, 11i, 11l, and 11m, may be TNIK-targeted candidate molecules for CRC treatment and show encouraging potential. Further experimental tests against specific TNIK proteins may need to confirm and extend these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Education, University of Sulaimani, Old Campus, 46001, Kurdistan Region, Iraq; College of Science, Department of Medical Laboratory Science, Komar University of Science and Technology…
- Department of Chemistry, Faculty of Arts and Sciences, Bolu Abant Izzet Baysal University, 14280, Bolu, Türkiye.
- Department of Chemistry, College of Science, Salahaddin University, Erbil, Kurdistan Region, Iraq; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region, Ir…
- Department of Chemistry, Faculty of Arts and Sciences, Bolu Abant Izzet Baysal University, 14280, Bolu, Türkiye. Electronic address: muhammetyildirim@ibu.edu.tr.
- Department of Chemistry, College of Science, University of Sulaimani, Sulaimaniyah, Kurdistan Region, Iraq.
Förderung
- Salahaddin University-Erbil
- Bolu Abant İzzet Baysal University
Zitieren
APA
Ahmed, H. I., Yazıcı, O. C., Abdullah, F. O., Yildirim, M., & Hamah Ameen, B. A. (2025). Synthesis, in vitro and in silico anticancer evaluations of novel styryl 1,3,4-oxadiazole-sulfonamide hybrids for colorectal cancer. Bioorganic & Medicinal Chemistry, 131, 118409. https://doi.org/10.1016/j.bmc.2025.118409
Vancouver
Ahmed HI, Yazıcı OC, Abdullah FO, Yildirim M, Hamah Ameen BA. Synthesis, in vitro and in silico anticancer evaluations of novel styryl 1,3,4-oxadiazole-sulfonamide hybrids for colorectal cancer. Bioorganic & Medicinal Chemistry. 2025;131:118409. doi:10.1016/j.bmc.2025.118409
BibTeX
@article{Ahmed2025,
author = {Ahmed, Hawkar I and Yazıcı, Onur Can and Abdullah, Fuad O and Yildirim, Muhammet and Hamah Ameen, Baram A},
title = {Synthesis, in vitro and in silico anticancer evaluations of novel styryl 1,3,4-oxadiazole-sulfonamide hybrids for colorectal cancer},
journal = {Bioorganic & Medicinal Chemistry},
year = {2025},
volume = {131},
pages = {118409},
doi = {10.1016/j.bmc.2025.118409}
}
EUVIMED